In this episode of the Crux of Medtech Henry is joined by Thomas Looby, CEO of Conavi Medical.
Thomas breaks down why combining IVUS + OCT in a single catheter could change coronary interventions and how the team is pacing toward a Q3 2025 510(k) with a measured “crawl, walk, run” launch plan.
Expect candid insight on evidence, pricing, commercialisation, and strategic exit logic
Key Topics
The unmet need in PCI imaging and why single-modality tools leave blind spots.
Engineering IVUS + OCT into one catheter and testing lessons from v1 to next-gen.
Clinical evidence momentum: meta-analysis signals ~46% reduction in post-procedure mortality and ~52% less stent thrombosis.
Regulatory path: pre-sub complete; targeting a Q3 2025 510(k).
Commercial strategy: price-neutral entry, razor/razor-blade model, and a staged hospital rollout.
Capital story: public listing via Titan assets and a $20M raise led largely by U.S. investors.
Exit thinking: platform fit with strategics that currently have either IVUS or OCT Kanavi holds both.
Related Insights
Mission-driven teams as a magnet for top engineers and why it mattered here.
Don’t over-index on KOLs: early adopters forgive product “sins” that mainstream users won’t.
Market development should run in parallel with R&D, not after it.Canada-born tech, U.S.-centric commercialisation and how ecosystems and manufacturing partners align.
Core Challenges
Driving COGS down to single-modality parity at volume (supply chain, manufacturing).
Building broad market awareness beyond early KOL enthusiasm.
Navigating regulatory milestones cleanly to stay on a Q3 2025 filing cadence.
Competing with entrenched portfolios (Abbott, Philips, Boston) that bundle cath lab solutions.
Tune in now to learn how dual-modality imaging could reset outcomes, economics, and adoption in the cath lab.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
This episode of the Crux of Medtech features Sabine Bois, the former CEO of Occlutech.
Sabine is a medtech leader whose career spans founding startups, steering a company through bankruptcy, driving IPO prep, and ultimately leading as CEO.
Her story is raw, unfiltered, and filled with lessons about resilience, leadership, and navigating the brutal realities of medtech.
Key Topics:
Sabine’s leap from small-town Germany to founding her first medtech startup
Navigating bankruptcy and rebuilding into a successful acquisition
The commercial lessons that reshaped her career trajectory
Transition from CFO to CEO at Occlutech during global litigation and IPO prep
The turbulence behind IPO readiness, audits, and roadshows
Why passion and relentlessness matter more than resources
Related Insights:
Failure wasn’t an option for the Wright brothers or for startups
The CEO’s ability to adapt their pitch can make or break funding
Timing and market cycles are often as critical as technology
Strategics are approachable but require careful balance in what you share
Core Challenges:
Surviving insolvency while protecting IP and technology
Learning that a CEO’s first responsibility is revenue, not admin
Facing last-minute IPO derailments and high-stakes investor negotiations
Adjusting from European regulatory norms to the strict demands of the FDA
Raising funds in today’s tougher, profitability-driven investor landscape
Tune in now to hear Sabine’s unfiltered journey through medtech’s toughest challenges and what it really takes to lead with resilience.
In this episode, Henry Norton speaks with Adrian Mendes, CEO of Perimeter, a company using AI and optical imaging to tackle one of cancer surgery’s biggest problems: re operations
Adrian shares his journey from Silicon Valley tech to medtech, and unpacks how Perimeter is using real-time imaging and machine learning to give surgeons confidence they’ve removed all the cancer the first time.
They discuss the challenges of moving fast in healthcare, the value of proprietary data in AI, and how Perimeter is building for scale with a clear commercial and clinical roadmap.
Key Topics:
Why reoperations are such a huge problem in cancer care
How OCT and AI work together during surgery
The culture problem slowing down medtech innovation
What sets “real” AI apart from buzzword AI
Commercial rollout plans and how they’re scaling
The long-term vision to expand beyond breast cancer
Related Insights:
“Clear margins” are one of the biggest unmet needs in cancer surgery
AI in healthcare is only useful if it's usable surgeon workflow matters
Proprietary data is more defensible than algorithms alone
Core Challenges:
Healthcare’s cautious culture often slows meaningful innovation
Many “AI” medtech products are just marketing
Commercial scale is hard when you’re building from a startup base
🎧 Tune in now to hear how Perimeter is building medtech that actually makes surgery smarter.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Why are so few patients accessing the care they need when the tech is already here? In this episode, Henry Norton sits down with David Pettigrew CEO at my mhealth to unpack the real reasons digital health tools succeed or fail.
From overlooked rehabilitation gaps to the power of patient-first design, this conversation spotlights how we can actually get medtech into the hands of the people who need it most.
David shares his career pivot from corporate dream job to healthtech entrepreneur, and what it’s really like building products that serve thousands of patients. You’ll hear why uptake often has nothing to do with clinical data… and everything to do with how a product makes someone feel.
Key Topics
Why David left a “dream job” for a mission-driven startup
How digital health tools can close the rehab gap
What makes an app truly “sticky” for users
The business model tensions slowing down innovation
Lessons from working directly with patients, not just clinicians
Related Insights
Core Challenges
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
In this episode, your host, Henry Norton, is joined by Hannah Claridge, the Head of Neurotechnology at TTP, to talk about the incredible advancements that are being made to treat neurological conditions.
Hannah points out how complex the brain and nervous systems are, with both relying on intricate connections. She also explores the new technologies that are being developed to treat nervous disorders, such as spinal cord stimulation.
She also compared neurotechnologies to pharmaceuticals, highlighting the parallels and differences in how they interact with the body.
Hannah also suggested that neurotherapy will be key to the advancement of treatments for conditions like depression, due to their ability to provide targeted and long-term relief of symptoms.
Cybersecurity is also a major concern for neurotechnology, as any malfunction or deliberate interference could have serious ramifications for patients.
Key Topics:
Hannah’s current role at TTP
Recent innovations in neurotechnology
Policy and ethics in neurotech
Barriers to market adoption
Moving patient stories
Related Insights:
Humans use far more than 10% of the brain - this was debunked during a conversation about brain plasticity
There are significant barriers to market adoption for neurosurgery, such as a lack of awareness and understanding, even among surgeons.
Neurotech’s impact on patients cannot be understated, as so many conditions are currently untreatable with other intervention methods.
Core Challenges:
Anything that interacts with the brain in a way that changes its fundamental functions comes with huge ethical concerns and a need for heightened patient understanding and clear consent.
Neurotechnology can provide relief for chronic conditions, such as long-term pain relief and the alleviation of depressive symptoms, making it a game-changing device in several areas.
The challenges when it comes to developing a new neurotech product from being intuitive to miniaturisation.
Tune in now to find out how neurotechnology will change healthcare for the better.
Raising capital in Medtech is tougher than ever. Investor expectations have shifted. Competition is up. And many founders are still pitching like it’s 2018.
In this episode, Henry Norton sits down with Kiko Filipov, Partner at APPARIUS Corporate Finance and Strategic Advisor at Cruxx, to unpack the real mechanics of a successful fundraise in 2025. From first-in-human data to commercial readiness, Kiko shares what separates the rounds that get oversubscribed from the ones that stall.
He also explores the changing landscape of Medtech innovation and why strategic exits take years of planning, how emerging markets are joining the race, and where VCs are placing bets across surgical robotics, neurostimulation, and digital health.
Whether you're gearing up for Series A or preparing your pitch deck, this episode delivers tactical clarity from someone who’s in the room with both founders and funds.
Key Topics:
What VCs actually look for in a Medtech pitch
Building an equity story that sells
Why surgical robotics and neurostimulation are hot right now
The key traits of an acquirable company
Common reasons fundraises fall flat
Related Insights:
Strategic hires matter just as much as the product
Market conditions now demand clearer commercial pathways
Software alone isn't enough, hybrid models are rising
Investors are more risk-averse and selective than ever
Core Challenges:
More competition than ever for VC attention
Delayed investment timing across the board
Burnout risk from unstructured fundraising efforts
Difficulties scaling across fragmented EU markets
🎧 Tune in now to learn what it really takes to raise and exit in Medtech.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Join host Henry Norton in this episode of The Crux of Medtech as he speaks to Paul Roberts, co-founder of CMR Surgical and current CEO of Lupin Dental.
Paul shares the journey from building surgical robots in a former pig shed to co-founding one of the most recognised names in robotic surgery. Now, he’s applying that experience to an entirely new frontier, aesthetic dental robotics.
In this episode, Paul explains why dental veneers are about more than vanity, how robotic precision can eliminate outdated practices like tooth stumping, and why Lupin’s tech could completely transform smile restoration.
He also opens up about his medtech philosophy, including why engineers shouldn’t build products alone, and what it really takes to move from zero to launch in a capital-intensive field like robotics.
Key Topics
Why Paul left surgical robotics for dental robotics
The founding story of CMR Surgical
The clinical and aesthetic importance of veneers
How Lupin reduces a 5-visit dental process into 1
What medtech can learn from AlignTech and Invisalign
Building a profitable robot company without hundreds of millions
Related Insights
Crowns are outdated. Robotic veneers restore enamel with less damage
Engineers alone don’t make great products clinicians must co-create
One robotic session at Lupin replaces five traditional dental visits
India is a strategic first market and a smart regulatory play
Fail fast, but never compromise on patient safety
Core Challenges
Tooth restoration has long been inefficient: dentists rely on hand-guesswork for shaping and prepping teeth. It’s a manual, error-prone process that requires multiple appointments and can cause long-term sensitivity.
Lupin Dental solves this with AI-powered planning, CAD design, and a precision robot that prepares the tooth and bonds the veneer all in one session.
Tune in now to hear how surgical-grade robotics are reshaping the smile economy and why Lupin Dental could be the next CMR.
*The Lupin® Robotic System is not currently approved for clinical use in USA or EU.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Meet Peter Verrillo, the CEO of Redefine Surgery. He joins your host, Henry Norton, in this episode to discuss the latest developments in orthopaedic AI.
Throughout the conversation, Peter highlights how time-consuming knee surgery can be, and talks about the AI solutions that his company is creating to reduce the time spent in theatre.
Peter also shares his journey as a founder of multiple different companies, touching on everything from funding and acquisitions to building prototypes in his basement.
He also emphasises the benefits of working with device-manufacturing companies, as they will take his AI to market under a whitelabel. He states that this relationship is a key part of the medtech industry.
Peter also touches on the importance of strong sales reps, suggesting that they should have training in both the software and robotics sides of this new technology in order to efficiently translate it to surgeons.
Key Topics:
Peter’s journey from Stryker to founding his own companies
The benefits of AI-assisted surgical technology
The entrepreneurial spirit
Redefine Surgery’s vision for the future of orthopaedic procedures
Finding the right people for a medtech team
Related Insights:
Fully understanding your patient’s problem before incision is key to a quick surgery
AI isn’t a mystical system anymore - it’s a key part of the future of surgery
Creating your own team from scratch can be easier than slotting into an existing group
Core Challenges:
Knee surgery often takes 45 minutes per person due to the need for readjustments once surgeons can see inside the joint.
With AI-assisted technology, the time to operate can be brought down to as little as ten minutes thanks to preoperative assessments.
Tune in now to find out how orthopaedic surgery will change in the coming years.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Join your host, Henry Norton, and David Caumartin, the CEO of RebrAIn, as they discuss the impact that machine learning and artificial intelligence are having on the clinical outcomes of neurosurgery procedures.
During the episode, David shares his medtech story, from how he entered the field to what drew him to RebrAIn several years ago.
He also talks about his experience of working with neurosurgeons and how that differs from the other fields he specialised in, such as mammography.
David goes on to discuss the benefits of AI in the surgical space, suggesting that it can improve surgeons’ accuracy, patient outcomes and medical research.
He also touched on RebrAIn’s clinical trials and the findings that are emerging from them.
Key Topics:
David’s transition from GE to startup
RebrAIn’s unique AI technology
The challenges and opportunities within the US market
The impact of AI on healthcare
Related Insights:
AI is making healthcare smarter, faster, and more efficient
Collaboration is the key to progress in the healthcare field
RebrAIn’s technology can create accurate targets from 100 cases rather than 20,000
Core Challenges:
The brain is one of the most delicate parts of human anatomy. In order to successfully operate on it, surgeons have to be as precise as possible. Factors like hand tremors, indecision or human error can have a huge impact on patient outcomes.
With an AI assistant, surgeons can assess the best course of action more quickly and accurately. RebrAIn’s AI tool serves as another neurosurgeon in the room.
Tune in now to discover the future of neurosurgery.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
In this episode, your host, Henry Norton, is joined by Dimitri Sokolov, the CEO at Spiro Robotics, to talk about the limitations of laryngoscopy tools, and what Spiro is doing to remove them.
Dimitri explained the difficulties with current intubation methods, as well as the dangers of unsuccessful procedures.
He went on to discuss the challenges of getting FDA approval for a new piece of medical robotics.
Dimitri also shared some of the adjustments he’s had to make as he moved into the role of CEO, particularly in a small company. This includes growing a team and equipping them to perform at their full capacity.
He also shared his story of getting into medical engineering.
Key Topics:
Dimitri’s path to joining Spiro Robotics
The challenges of tracheal intubation
Precision-based solutions to medical interventions
How robotics can solve staffing shortages
Related Insights:
The trials of clinical submissions
The value of clinical studies and partnerships
The opportunities for global advancements
Core Challenges:
Tracheal intubation is currently difficult for a lot of reasons, and often leads to cancelled surgeries in more troublesome cases. This is an issue for patients, surgeons, and anesthesiologists.
Spiro Robotics have created an intubation solution that enables quicker and more precise procedures, while also removing the need for a second physician in the room.
Listen in to this episode to find out more about intubating safely and effectively.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Meet this week’s guest, Olivier Delporte, the CEO of SamanTree Medical. He joined me, your host, Henry Norton, to discuss his company’s game-changing imaging technology, which is set to improve surgical outcomes for cancer patients in the breast and prostate areas.
Oliver also has an extensive background in venture capital, which he says compliments his role as CEO, as it allows him to build the company to a point that it is attractive to investors.
He also discussed the innovations behind the Histolog Scanner, including the current imaging systems and their failings, which prompted SamanTree Medical to create their device in the first place.
Oliver also focuses on patient outcomes, citing the lowered need for reintervention as one of his company’s scanners’ biggest achievements, particularly when treating breast cancer.
He shared some of the wider applications that the scanner could be used for, including lung, urology and thoracic procedures.
Key Topics:
Oliver’s background and career journey, including the insights he’s gained from it
Venture capitalists’ interest in medical technology
The Histolog Scanner and its clinical purposes
The impact of AI on the scanner’s further development
Related Insights:
The benefits of clinical data for market expansion
Commercialisation strategies
The need for high-performing people in smaller startups
Core Challenges:
Previous imaging procedures, such as frozen section analysis, aren’t suitable for current clinical needs. Surgeons need faster, more reliable imaging systems in order to make the best decisions for their patients and provide better outcomes for the people in their care.
The Histolog Scanner provides faster imaging services and is set to provide readings, analysis and other support as AI technology advances. This will help surgeons make faster and better decisions while operating.
Listen in to this fascinating episode that covers everything from funding and partnerships to human interest stories and life-altering surgical procedures.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
This episode of the Crux of Medtech podcast has not one, but two guests, who joined me at TTP’s offices for an exciting conversation about the future of surgical robotics - and that’s the best name for the technology we’re exploring.
I’m delighted to introduce Paul Galluzzo, Head of Surgical Intervention and Imaging at TTP, and Steve Bell, an independent Medtech startup advisor.
They discussed the ways that our technology needs to evolve in order to improve surgical outcomes and quality of life for patients, as well as the enhanced laparoscopic applications for more advanced remote surgeries.
Steve and Paul also talked about the benefits of a build-to-buy startup, and the challenges that other startups face when they’re building and selling their surgical robots.
That included juggling competing priorities from investors and end buyers, as well as the need to solve challenges while understanding their customers’ needs.
Key Topics:
Current trends in surgical robotics
How surgeon needs will shape the medical technology of the future
Commercial involvement in research and development
Advice for medtech startup founders
Related Insights:
The need for AI support for surgeons
Why investors should continue to support medtech startups
The importance of commercial advice from day one in startups
Core Challenges:
Laparoscopic robotics aren’t dextrous enough to provide surgeons with the maneuverability that they need for more complex procedures without compromising their patients’ quality of life.
Upcoming surgical robotics should meet these needs with enhanced personalisation and increased haptic feedback, enabling even relatively inexperienced surgeons to perform more complex procedures effectively.
Tune in now for insightful advice about startup strategies and the ongoing need for improved surgical robotics.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Welcome to the first ever episode of the Crux of MedTech podcast!
I’m your host, Henry Norton, and in this series I’ll be introducing you to some of the leading innovators and investors in the surgical robotics space, to share their stories and insights.
This week, I’m joined by Manios Dimitrakakis, the CEO of Panda Surgical.
He talks about his journey from academia to industry, following his path from post-graduate researcher to his current role as CEO of an exciting young MedTech company.
Manios shares his perspectives on why neurosurgery is falling behind surgical fields like laparoscopy when it comes to their surgical robotics and other similar tools, as well as what he, and the rest of the Panda Surgical team, are doing to change that.
Key Topics:
- The technical and economic barriers that have slowed innovation
- How Panda Surgical is improving precision and safety with handheld robotic tools
- The challenges of transitioning from academic research to a commercial product
- The role of surgeon feedback in refining robotic surgical devices
Company Insights:
- Preparing for their first-in-human trials
- Raising Series A funding to accelerate development of their device
- Expanding into U.S., European, and APAC markets
Core Challenges:
- Despite major advances in robotic surgery, neurosurgeons still rely on outdated instruments that limit precision.
- Panda Surgical is addressing this gap with a handheld robotic system designed for minimally invasive brain and spine procedures.
Listen in for some fascinating inside information about the creation of Panda Surgical’s robotic device, and where Manios plans to take it, and the company, next.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
&
KUKA is a global leader in robotics with over 25 years of experience partnering with medtech companies on their journey to market. Their reputation is built on robust technology, reliability and long term collaboration and being more than just a supplier.
KUKA provides trusted support throughout the product life cycle, from development to integration and beyond.
Find out more at kuka.com/healthcare
Discover the importance of strong value propositions when developing a new surgical robot with your host, Henry Norton, and Paul Galluzzo, the ??? at The Technology Partnership (TTP).
Paul also shared his predictions for upcoming technologies in the surgical robotics industry, including augmented reality and artificial intelligence, as they continue to enhance surgeons’ skills.
He also shared his insights on what makes a business in the sector successful, citing the importance of resources and market share when taking a new robot to market.
Paul also shared some of the innovative solutions that TTP are creating, emphasising the role of academic research in producing new technology.
Tune in to learn more about the role of purpose and precision in surgical robotics.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
Take a look at the inner workings of Distalmotion with CEO Greg Roche and your host, Henry Norton, in this fascinating episode!
Greg shared the importance of the company’s value proposition in taking Dexter, their surgical robot, to a global market.
They also touched on the evolution of surgical robotics, both in technical terms and its increasing adoption in new generations of surgeons.
Tune in to discover more about innovation in smaller surgical robotics players.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
Delve into the topic of evidence and value-based medicine with your host, Henry Norton, and Mark Slack, the Chief Medical Officer and Co-Founder of CMR Surgical.
Mark joined us to share his experience of working with surgical robotics and the impact they have on patient outcomes.
He also shared his perspective on using untested technologies and the serious impact this can have on the health and wellbeing of hundreds, or even thousands, of patients.
Throughout the conversation he highlighted the importance of patient-first care, stating that patient-centricity is the most human element of healthcare.
Tune in to find out more about the history and future of surgical robotics.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
Explore the applications of ultrasound in surgical robotics with your host, Henry Norton, and Nico Fenu, the Co-Founder and CEO of Nami Surgical.
Nico explained the variety of ultrasound applications within the surgical robotics industry, from ultrasonic imaging to biopsies and precision surgery.
He also explained the technical side of developing an ultrasound application, as well as Nami Surgical’s process of spinning out from a university research centre.
Tune in to hear more about this exciting branch of surgical development.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
Explore the realms of sports medicine and arthroscopy with your host, Henry Norton, and Chris Jeffery, the CEO of Convergence Medical.
Chris explained his journey into arthroscopy, touching on his history as a three-time founder and his passion for improving healthcare.
They also discussed the importance of adapting technology to changing market demands, from financial constraints to surgeon’s limited capabilities.
Tune in to hear more about improving accuracy and dexterity with surgical robotics.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
Discover telesurgery’s fascinating origin and future in this double-feature episode with Cynthia Perazzo and Yulun Wang, the Co-Founders of Sovato.
Your host, Henry Norton, guided the conversation through topics such as patient-driven adoption to the potential for healthcare revolution.
Cynthia and Yulun also discussed surgeon shortages and the accessibility challenges facing more rural and remote populations in receiving a high standard of care.
Listen in to learn more about technology’s role in transforming healthcare in the coming years.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
Explore the complexity of clinical data with Bjoern von Siemens, the Founder of Caresyntax and this week’s guest speaker.
In this episode, hosted by Henry Norton, Bjoern discussed the future of MedTech, including the role that data and AI will play in developing the technology that is currently set to transform surgery for future generations.
They also touched on the importance of reducing the cost of care and making safe surgery accessible to everyone.
Tune in to learn more about the role of automation and analytics in developing the surgical robotics industry.
The Surgibots Podcast is brought to you by Cruxx, a specialist surgical robotics recruitment company that was founded by your host, Henry Norton.
To learn more about Cruxx, click here.
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies.
Learn more at TTP.com&FundamentalVR revolutionises surgical training with its immersive VR and haptic platforms, offering realistic simulations for surgeons. Specializing in surgical robotics, orthopedics, and more, they provide hands-on experience without the need for physical labs.
Learn more at FundamentalVR.com
